Importance of Patient Health Insurance Coverage and Out-of-Pocket Costs for Genomic Testing in Oncologists' Treatment Decisions.
K Robin YabroffSylvia Kewei ShiJingxuan ZhaoAndrew N FreedmanZhiyuan ZhengLeticia M NogueiraXuesong HanCarrie N KlabundeJanet S de MoorPublished in: JCO oncology practice (2024)
Most oncologists rate patient health insurance and OOP costs for genomic tests as important considerations in subsequent treatment recommendations. Modifiable factors associated with these ratings can inform interventions to support patient-physician decision making about care.